ScholarIQanswers from OpenAlex
Casa di Cura Villa Garda
InstitutionResearch output, impact & collaborations
Casa di Cura Villa Garda is a institution indexed in ScholarIQ from OpenAlex.
What is known about Casa di Cura Villa Garda?
ScholarIQrecord summary
Casa di Cura Villa Garda is a research organisation in Garda, IT. OpenAlex records 2,071 works and 77,785 citations for it. 581 researchers list it as their most recent affiliation.
How many works does Casa di Cura Villa Garda have?
ScholarIQindexed works
Casa di Cura Villa Garda has 2,071 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Casa di Cura Villa Garda have?
ScholarIQcitation count
Casa di Cura Villa Garda has 77,785 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Casa di Cura Villa Garda?
ScholarIQresearcher count
Casa di Cura Villa Garda has 581 researchers in the ScholarIQ index.
What is the average h-index at Casa di Cura Villa Garda?
ScholarIQavg h-index
Casa di Cura Villa Garda has an average h-index of 39 in OpenAlex.
What is the ROR of Casa di Cura Villa Garda?
ScholarIQror
The ROR for Casa di Cura Villa Garda is on the source record.
What is the OpenAlex record for Casa di Cura Villa Garda?
ScholarIQopenalex
The OpenAlex for Casa di Cura Villa Garda is on the source record.
Who are the most-cited researchers behind Casa di Cura Villa Garda?
ScholarIQtop researchers by citations
What are the most-cited papers on Casa di Cura Villa Garda?
ScholarIQmost cited works
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Paolo A. Ascierto, Michele Del Vecchio, Mario Mandalà, Helen Gogas, Ana Arance, Stéphane Dalle, C. Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion‐Sileni, Iván Márquez‐Rodas, Marcus O. Butler, Michele Maio, Mark R. Middleton, Luis de la Cruz‐Merino, Petr Arenberger, Victoria Atkinson, Andrew Hill, Leslie A. Fecher, Michael Millward, Nikhil I. Khushalani, Paola Queirolo, Maurice Lobo, Veerle de Pril, John T. Loffredo, James Larkin, Jeffrey S. Weber
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma
Ermanno Ancona, Alberto Ruol, Stefano Santi, Stefano Merigliano, Vanna Chiarion‐Sileni, H. Koussis, Giovanni Zaninotto, Luigi Bonavina, Alberto Peracchia
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli, Luca Mulazzani, Francesco Graziano, Paolo Giordani, Andrea Mambrini, Francesco Montagnani, Paolo Alessandroni, Vincenzo Catalano, Paolo Coschiera
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
Maria Vittoria Davì, Luca Dalle Carbonare, Andrea Giustina, Marcello Ferrari, Anna Chiara Frigo, Vincenzo Lo Cascio, Giuseppe Francia
Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy
Alberto Cipriani, Barbara Bauce, Manuel De Lazzari, Ilaria Rigato, Riccardo Bariani, Samuele Meneghin, Kalliopi Pilichou, Raffaella Motta, Camillo Aliberti, Gaetano Thiene, William J. McKenna, Alessandro Zorzi, Sabino Iliceto, Cristina Basso, Martina Perazzolo Marra, Domenico Corrado
How much of the research on Casa di Cura Villa Garda is open access?
ScholarIQopen access share
25%OPEN ACCESS